Skip to content

Adjunctive acetaminophen therapy for Major Depression

Adjunctive acetaminophen therapy for Major Depression - Adjunctive acetaminophen therapy for Major Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007877
Enrollment
20
Registered
2012-05-02
Start date
2010-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Adjunctive acetaminophen therapy for Major Depression

Sponsors

Oizumi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1,Patients with major depressive disorder (DSM-4) 2,20 to 80 years of age, were recruited. 3,They were required to show no remarkable change of symptom more than 4weeks under the same medications. Patients who showed less than 20% improvements in the Montgomery-Asberg Depression Rating Scale (MADRS) from screening to baseline were included to the study.

Exclusion criteria

Exclusion criteria: 1,Having a serious physical disease.. 2,The presence of previous history of side effects or allergy about Acetaminophen 3,Past history of asthma 4,Past history of heart disease 5,Past history of upper gastrointestinal disease such as gastritis 6,Blood disease 7,Bleeding tendency 8,Liver disease 9,Renal disease 10,Heavy drinker 11,Malnutrition 12,Manic-depressive illness 13,Epilepsy 14,More than 5 points of suicidal thoughts MADRS 15,The presence of psychotic symptom 16,There is no therapeutic response to antidepressants for more than three drugs in the past 17,Pregnant or Breast-feeding 18,Those taking anticoagulants such as Warfarin, Those taking thiazide diuretics, quinolone antibiotics, lithium, carbamazepine, phenobarbital, phenytoin, primidone 19,Those already taking the medicines that contain acetaminophen

Design outcomes

Primary

MeasureTime frame
Montgomery-Asberg Depression Scale (MADRS)

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026